Skip to main content

Advertisement

Log in

Multiregional-based magnetic resonance imaging radiomics model for predicting tumor deposits in resectable rectal cancer

  • Hollow Organ GI
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To establish and validate an integrated model incorporating multiregional magnetic resonance imaging (MRI) radiomics features and clinical factors to predict tumor deposits (TDs) preoperatively in resectable rectal cancer (RC).

Methods

This study retrospectively included 148 resectable RC patients [TDs+ (n = 45); TDs (n = 103)] from August 2016 to August 2022, who were divided randomly into a testing cohort (n = 45) and a training cohort (n = 103). Radiomics features were extracted from the volume of interest on T2-weighted images (T2WI) and diffusion-weighted images (DWI) from pretreatment MRI. Model construction was performed after feature selection. Finally, five classification models were developed by support vector machine (SVM) algorithm to predict TDs in resectable RC using the selected clinical factor, single-regional radiomics features (extracted from primary tumor), and multiregional radiomics features (extracted from the primary tumor and mesorectal fat). Receiver-operating characteristic (ROC) curve analysis was employed to assess the discrimination performance of the five models. The AUCs of five models were compared by DeLon’s test.

Results

The training and testing cohorts included 31 (30.1%) and 14 (31.1%) patients with TDs, respectively. The AUCs of multiregional radiomics, single-regional radiomics, and the clinical models for predicting TDs were 0.839, 0.765, and 0.793, respectively. An integrated model incorporating multiregional radiomics features and clinical factors showed good predictive performance for predicting TDs in resectable RC (AUC, 0.931; 95% CI, 0.841–0.988), which demonstrated superiority over clinical model (P = 0.016), the single-regional radiomics model (P = 0.042), and the multiregional radiomics model (P = 0.025).

Conclusion

An integrated model combining multiregional MRI radiomic features and clinical factors can improve prediction performance for TDs and guide clinicians in implementing treatment plans individually for resectable RC patients.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, Jemal A(2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin 68 (6):394-424. https://doi.org/https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Keum N, Giovannucci E(2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.Nat Rev Gastroenterol Hepatol 16 (12):713-732. https://doi.org/https://doi.org/10.1038/s41575-019-0189-8

    Article  PubMed  Google Scholar 

  3. Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng P, Xu P, Zhu D, Ji M, Xu J(2015) Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases.Onco Targets Ther 8233-240. https://doi.org/https://doi.org/10.2147/ott.S71414

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lord A C, D’Souza N, Pucher P H, Moran B J, Abulafi A M, Wotherspoon A, Rasheed S, Brown G(2017) Significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis.Eur J Cancer 8292-102. https://doi.org/https://doi.org/10.1016/j.ejca.2017.05.027

    Article  PubMed  Google Scholar 

  5. Ueno H, Hashiguchi Y, Shimazaki H, Shinto E, Kajiwara Y, Nakanishi K, Kato K, Maekawa K, Nakamura T, Yamamoto J, Hase K (2014) Peritumoral deposits as an adverse prognostic indicator of colorectal cancer.Am J Surg 207 (1):70-77. https://doi.org/https://doi.org/10.1016/j.amjsurg.2013.04.009

    Article  PubMed  Google Scholar 

  6. Diagnosis, Treatment Guidelines For Colorectal Cancer Working Group C(2019) Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version).Chin J Cancer Res 31 (1):117-134. https://doi.org/https://doi.org/10.21147/j.issn.1000-9604.2019.01.07

    Article  Google Scholar 

  7. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D(2018) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol 29 (Suppl 4):iv263. https://doi.org/https://doi.org/10.1093/annonc/mdy161

    Article  CAS  PubMed  Google Scholar 

  8. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima T E, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K(2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.Int J Clin Oncol 25 (1):1-42. https://doi.org/https://doi.org/10.1007/s10147-019-01485-z

    Article  PubMed  Google Scholar 

  9. Jin M, Frankel W L (2018) Lymph Node Metastasis in Colorectal Cancer.Surg Oncol Clin N Am 27 (2):401-412. https://doi.org/https://doi.org/10.1016/j.soc.2017.11.011

    Article  PubMed  Google Scholar 

  10. Pricolo V E, Steingrimsson J, McDuffie T J, McHale J M, McMillen B, Shparber M(2020) Tumor Deposits in Stage III Colon Cancer: Correlation With Other Histopathologic Variables, Prognostic Value, and Risk Stratification-Time to Consider “N2c”.Am J Clin Oncol 43 (2):133-138. https://doi.org/https://doi.org/10.1097/coc.0000000000000645

    Article  PubMed  Google Scholar 

  11. Washington M K, Berlin J, Branton P, Burgart L J, Carter D K, Fitzgibbons P L, Halling K, Frankel W, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton C C(2009) Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.Arch Pathol Lab Med 133 (10):1539-1551. https://doi.org/https://doi.org/10.5858/133.10.1539

    Article  PubMed  PubMed Central  Google Scholar 

  12. Nagtegaal I D, Knijn N, Hugen N, Marshall H C, Sugihara K, Tot T, Ueno H, Quirke P(2017) Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.J Clin Oncol 35 (10):1119-1127. https://doi.org/https://doi.org/10.1200/jco.2016.68.9091

    Article  PubMed  Google Scholar 

  13. Bouquot M, Creavin B, Goasguen N, Chafai N, Tiret E, André T, Flejou J F, Parc Y, Lefevre J H, Svrcek M(2018) Prognostic value and characteristics of N1c colorectal cancer.Colorectal Dis 20 (9):O248-o255. https://doi.org/https://doi.org/10.1111/codi.14289

    Article  CAS  PubMed  Google Scholar 

  14. Yagi R, Shimada Y, Kameyama H, Tajima Y, Okamura T, Sakata J, Kobayashi T, Kosugi S I, Wakai T, Nogami H, Maruyama S, Takii Y, Kawasaki T, Honma K I (2016) Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions.Ann Surg Oncol 23 (Suppl 4):552-558. https://doi.org/https://doi.org/10.1245/s10434-016-5379-9

    Article  PubMed  PubMed Central  Google Scholar 

  15. Weiser M R (2018) AJCC 8th Edition: Colorectal Cancer.Ann Surg Oncol 25 (6):1454-1455. https://doi.org/https://doi.org/10.1245/s10434-018-6462-1

    Article  PubMed  Google Scholar 

  16. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D(2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol 28 (suppl_4):iv22-iv40. https://doi.org/https://doi.org/10.1093/annonc/mdx224

    Article  CAS  PubMed  Google Scholar 

  17. Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim D H(2019) Rectal cancer MR staging: pearls and pitfalls at baseline examination.Abdom Radiol (NY) 44 (11):3536-3548. https://doi.org/https://doi.org/10.1007/s00261-019-02024-0

    Article  Google Scholar 

  18. Fernandes M C, Gollub M J, Brown G(2022) The importance of MRI for rectal cancer evaluation.Surg Oncol 43101739. https://doi.org/https://doi.org/10.1016/j.suronc.2022.101739

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hoshino N, Murakami K, Hida K, Sakamoto T, Sakai Y(2019) Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis.Int J Clin Oncol 24 (1):46-52. https://doi.org/https://doi.org/10.1007/s10147-018-1349-5

    Article  CAS  PubMed  Google Scholar 

  20. Li X T, Sun Y S, Tang L, Cao K, Zhang X Y(2015) Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis.Colorectal Dis 17 (6):O129-135. https://doi.org/https://doi.org/10.1111/codi.12909

    Article  PubMed  Google Scholar 

  21. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout R G, Granton P, Zegers C M, Gillies R, Boellard R, Dekker A, Aerts H J(2012) Radiomics: extracting more information from medical images using advanced feature analysis.Eur J Cancer 48 (4):441-446. https://doi.org/https://doi.org/10.1016/j.ejca.2011.11.036

    Article  PubMed  PubMed Central  Google Scholar 

  22. Antunes J T, Ofshteyn A, Bera K, Wang E Y, Brady J T, Willis J E, Friedman K A, Marderstein E L, Kalady M F, Stein S L, Purysko A S, Paspulati R, Gollamudi J, Madabhushi A, Viswanath S E(2020) Radiomic Features of Primary Rectal Cancers on Baseline T (2) -Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study.J Magn Reson Imaging 52 (5):1531-1541. https://doi.org/https://doi.org/10.1002/jmri.27140

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bi W L, Hosny A, Schabath M B, Giger M L, Birkbak N J, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn I F, Mak R H, Tamimi R M, Tempany C M, Swanton C, Hoffmann U, Schwartz L H, Gillies R J, Huang R Y, Aerts H(2019) Artificial intelligence in cancer imaging: Clinical challenges and applications.CA Cancer J Clin 69 (2):127-157. https://doi.org/https://doi.org/10.3322/caac.21552

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gillies R J, Kinahan P E, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data.Radiology 278 (2):563-577. https://doi.org/https://doi.org/10.1148/radiol.2015151169

    Article  PubMed  Google Scholar 

  25. Atre I D, Eurboonyanun K, Noda Y, Parakh A, O’Shea A, Lahoud R M, Sell N M, Kunitake H, Harisinghani M G(2021) Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort.Abdom Radiol (NY) 46 (2):459-468. https://doi.org/https://doi.org/10.1007/s00261-020-02653-w

    Article  Google Scholar 

  26. Chen L D, Li W, Xian M F, Zheng X, Lin Y, Liu B X, Lin M X, Li X, Zheng Y L, Xie X Y, Lu M D, Kuang M, Xu J B, Wang W(2020) Preoperative prediction of tumour deposits in rectal cancer by an artificial neural network-based US radiomics model.Eur Radiol 30 (4):1969-1979. https://doi.org/https://doi.org/10.1007/s00330-019-06558-1

    Article  PubMed  Google Scholar 

  27. Jin Y, Li M, Zhao Y, Huang C, Liu S, Liu S, Wu M, Song B(2021) Computed Tomography-Based Radiomics for Preoperative Prediction of Tumor Deposits in Rectal Cancer.Front Oncol 11710248. https://doi.org/https://doi.org/10.3389/fonc.2021.710248

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yang Y S, Feng F, Qiu Y J, Zheng G H, Ge Y Q, Wang Y T(2021) High-resolution MRI-based radiomics analysis to predict lymph node metastasis and tumor deposits respectively in rectal cancer.Abdom Radiol (NY) 46 (3):873-884. https://doi.org/https://doi.org/10.1007/s00261-020-02733-x

    Article  Google Scholar 

  29. Jayaprakasam V S, Paroder V, Gibbs P, Bajwa R, Gangai N, Sosa R E, Petkovska I, Golia Pernicka J S, Fuqua J L, 3rd, Bates D D B, Weiser M R, Cercek A, Gollub M J(2022) MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.Eur Radiol 32 (2):971-980. https://doi.org/https://doi.org/10.1007/s00330-021-08144-w

    Article  CAS  PubMed  Google Scholar 

  30. Liu X, Yang Q, Zhang C, Sun J, He K, Xie Y, Zhang Y, Fu Y, Zhang H(2020) Multiregional-Based Magnetic Resonance Imaging Radiomics Combined With Clinical Data Improves Efficacy in Predicting Lymph Node Metastasis of Rectal Cancer.Front Oncol 10585767. https://doi.org/https://doi.org/10.3389/fonc.2020.585767

    Article  PubMed  PubMed Central  Google Scholar 

  31. Shaish H, Aukerman A, Vanguri R, Spinelli A, Armenta P, Jambawalikar S, Makkar J, Bentley-Hibbert S, Del Portillo A, Kiran R, Monti L, Bonifacio C, Kirienko M, Gardner K L, Schwartz L, Keller D(2020) Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.Eur Radiol 30 (11):6263-6273. https://doi.org/https://doi.org/10.1007/s00330-020-06968-6

    Article  CAS  PubMed  Google Scholar 

  32. Pan A F, Zheng N X, Wang J, Kabemba J L T, Zheng K, Shen F, Zhang W, Gao X H(2022) Role of Perirectal Fat in the Carcinogenesis and Development of Early-Onset Rectal Cancer.J Oncol 20224061142. https://doi.org/https://doi.org/10.1155/2022/4061142

    Article  PubMed  PubMed Central  Google Scholar 

  33. Song Y, Zhang J, Zhang Y D, Hou Y, Yan X, Wang Y, Zhou M, Yao Y F, Yang G(2020) FeAture Explorer (FAE): A tool for developing and comparing radiomics models.PLoS One 15 (8):e0237587. https://doi.org/https://doi.org/10.1371/journal.pone.0237587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. van Griethuysen J J M, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan R G H, Fillion-Robin J C, Pieper S, Aerts H (2017) Computational Radiomics System to Decode the Radiographic Phenotype.Cancer Res 77 (21):e104-e107. https://doi.org/https://doi.org/10.1158/0008-5472.Can-17-0339

    Article  PubMed  PubMed Central  Google Scholar 

  35. Gopal P, Lu P, Ayers G D, Herline A J, Washington M K(2014) Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis.Mod Pathol 27 (9):1281-1287. https://doi.org/https://doi.org/10.1038/modpathol.2013.239

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ng F, Kozarski R, Ganeshan B, Goh V(2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis?Eur J Radiol 82 (2):342-348. https://doi.org/https://doi.org/10.1016/j.ejrad.2012.10.023

    Article  PubMed  Google Scholar 

  37. Braman N M, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A(2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.Breast Cancer Res 19 (1):57. https://doi.org/https://doi.org/10.1186/s13058-017-0846-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kickingereder P, Bonekamp D, Nowosielski M, Kratz A, Sill M, Burth S, Wick A, Eidel O, Schlemmer H P, Radbruch A, Debus J, Herold-Mende C, Unterberg A, Jones D, Pfister S, Wick W, von Deimling A, Bendszus M, Capper D (2016) Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.Radiology 281 (3):907-918. https://doi.org/https://doi.org/10.1148/radiol.2016161382

    Article  PubMed  Google Scholar 

  39. Li Z C, Bai H, Sun Q, Li Q, Liu L, Zou Y, Chen Y, Liang C, Zheng H(2018) Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.Eur Radiol 28 (9):3640-3650. https://doi.org/https://doi.org/10.1007/s00330-017-5302-1

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Jibo Jia (Department of Radiology, the Third People’s Hospital of Kunshan, No. 615 Zizhu road, Kunshan, Jiangsu Province 215003, China) for providing some suggestions on the data processing software used in our research.

Funding

This work was supported by Gusu health talent project of Suzhou (GSWS2020003)

Author information

Authors and Affiliations

Authors

Contributions

FWF and CHH participated in the conception/ design. YQL and JYB participated in the provision of study material or patients. JYB and RH participated in the collection and/or assembly of data. FWF and YQL participated in the data analysis and interpretation. FWF participated in the manuscript writing. SH and CHH participated in the manuscript revision. All authors contributed to final approval of manuscript.

Corresponding authors

Correspondence to Su Hu or Chunhong Hu.

Ethics declarations

Conflict of interest

All authors declare that there is no conflict of interest.

Ethical approval

This study was in accordance with the current ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 61 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, F., Liu, Y., Bao, J. et al. Multiregional-based magnetic resonance imaging radiomics model for predicting tumor deposits in resectable rectal cancer. Abdom Radiol 48, 3310–3321 (2023). https://doi.org/10.1007/s00261-023-04013-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-04013-w

Keywords

Navigation